Soluble interleukin-2 receptors increase during the active periods in cluster headache

Headache

Volumn 43, Issue 1, 2003, Pages 63-68

  Empl, Monika ^a   Forderreuther S ^a   Schwarz, M ^b   Muller N ^a   Straube, A ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cluster headache; Hypothalamus; Interleukin 6; Sgp130; Soluble interleukin 2 receptors; Soluble interleukin 6 receptors

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYTOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLUSTER HEADACHE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOREACTIVITY; INFLAMMATION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; CLUSTER HEADACHE; FEMALE; HUMANS; HYPOTHALAMUS; INTERLEUKINS; MALE; RECEPTORS, INTERLEUKIN-2; RECEPTORS, INTERLEUKIN-6; SOLUBILITY; T-LYMPHOCYTES;

EID: 0037253083     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2003.03011.x     Document Type: Article

References (32)

1. Hardebo JE. How cluster headache is explained as an intracavernous inflammatory process lesioning sympathetic fibers. Headache. 1994;34:125-131.
2. Blanchard BM. Cluster headache associated with parainfluenza virus, preceded and succeeded by migraine. Headache. 1998;38:132-134.
3. Joseph R, Rose FC. Cluster headache and herpes simplex: an association? BMJ. 1985;290:1625-1626.
4. Remahl IN, Waldenlind E, Bratt J, Ekbom K. Cluster headache is not associated with signs of systemic inflammation. Headache. 2000;40:276-281.
5. Leone M, Lucini V, D'Amico D, Moschiano F, Maltempo C, Fraschini F, Bussone G. Twenty-four-hour melatonin and cortisol plasma levels in relation to timing of cluster headache. Cephalalgia. 1995;15:224-229.
6. Leone M, Lucini P, D'Amico D, Grazzi L, Moschiano F, Fraschini F, Bussone G. Abnormal 24-hour urinary excretory pattern of 6-sulphatoxymelatonin in both phases of cluster headache. Cephalalgia. 1998;18:664-667.
7. May A, Bahra A, Buhel C, Frackowiak RSJ, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet. 1998;351:275-278.
8. Göbel H. Die Kopfschmerzen: Ursachen, Mechanismen, Diagnostik und Therapie in der Praxis. Berlin: Springer-Verlag; 1997.
9. Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminal activation in cluster headache. Neuropeptide changes and effects of acute attack therapies. Brain. 1994;117:427-434.
10. Roitt I, Brostoff J, Male D. Immunology, 5th ed. London: Mosby; 1998.
11. Buller KM, Xu Y, Day TA. Indomethacin attenuates oxytocin and hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1β. J Neuroendocrinol. 1998;10:519-528.
12. Wang J, Dunn AJ. The role of interleukin-6 in the activation of the hypothalamo-pituitary-adrenocortical axis and brain indoleamines by endotoxin and interleukin-1β. Brain Res. 1999;815:337-348.
13. McCann SM, Kimura M, Karanth S, Yu WH, Rettori V. Nitric oxide controls the hypothalamic-pituitary response to cytokines. Neuroimmunomodidation. 1997;4:98-106.
14. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH. The pivotal role of tumor necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol. 1992;107:660-664.
15. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre J, Woolf CJ. Interleukin-1β-mediated induction of cox-1 in the CNS contributes to inflammatory pain hypersensitivity. Nature. 2001;410:471-475.
16. Lin Q, Palecek J, Paleckova V, Peng YB, Wu J, Cui M, Willis WD. Nitric oxide mediates the central sensitization of primate spinothalamic tract neurons. J Neurophysiol. 1999;81:1075-1085.
17. Itoh M, Goto Y, Ohta Y, Goto Y, Ohashi H. Relations between surface expression of the interleukin-2 receptor and release of the soluble form of the receptor in cultured mononuclear cells from patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Rheumatol. 1998;17:26-30.
18. Merkel PA, Dooley MA, Dawson DV, Pisetsky DS, Polisson RP. Interleukin-2 receptor in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo. J Rheumatol. 1996;23:1856-1861.
19. Cho WH, Kim HT, Sohn CY, Park CH, Park SB, Kim HC. Significance of IL-2, IL-2R, IL-6, and TNF-α as a diagnostic test of acute rejection after renal transplantation. Transplant Proc. 1998;30:2967-2969.
20. Martelletti P, Stirparo G, De Stefano C, Di Sabato F, Giacovazzo M, Rinaldi-Garaci C. Defective expression of IL-2 receptors on peripheral blood lymphocytes from patients with cluster headache. Headache. 1990;30:228-231.
21. Ziegler-Heitbrock HW, Blumenstein M, Kafferlein W, Kieper D, Petersmann I, Endres S, Flegel WA, Northoff H, Riethmüller G, Haas JG. In vitro desensitization to lipopolysaccharide expression in a similar fashion. Immunology. 1992;75:264-268.
22. Martelletti P, Granata M, Giacovazzo M. Serum interleukin-1β is increased in cluster headache. Cephalalgia. 1993;13:343-345.
23. Sarlis NJ, Chowdrey HS, Stephanou A, Lightman SL. Chronic activation of the hypothalamo-pituitary-adrenal axis and loss of circadian rhythm during adjuvant-induced arthritis in the rat. Endocrinology. 1992;130:1775-1779.
24. Turnbull AV, Rivier C. Corticotropin-releasing factor, vasopressin, and prostaglandins mediate, and nitric oxide restrains, the hypothalamic-pituitary-adrenal response to acute local inflammation in the rat. Endocrinology. 1996;137:455-463.
25. Späth-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall, Burger K, Fehm HL, Born J. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endrocrinol Metab. 1998;83:1573-1579.
26. Glaser R, Kennedy S, Lafuse WP, Bonneau RH, Speicher C, Hillhouse J, Kiecolt-Glaser JK. Psycho-logical stress-induced modulation of interleukin-2 receptor gene expression and interleukin-2 production in peripheral blood leukocytes. Arch Gen Psychiatry. 1990;47:707-712.
27. Harrington L, Affleck G, Urrows S, Tennen H, Higgins P, Zautra A, Hoffman S. Temporal covariation of soluble interleukin-2 receptor levels, daily stress, and disease activity in rheumatoid arthritis. Arthritis Rheum. 1993;36:199-203.
28. Schulte HM, Bamberger CM, Elsen H, Herrman G, Bamberger AM, Barth J. Systemic interleukin-1α and interleukin-2 secretion in response to acute stress and to corticotropin-releasing hormone in humans. Eur J Clin Invest. 1994;24:773-777.
29. Cambronero JC, Rivas FJ, Borrell J, Guaza C. Interleukin-2 induces corticotropin-releasing hormone release from superfused rat hypothalami: influence of glucocorticoids. Endocrinology. 1992;131:677-683.
30. May A, Ashburner J, Buchel C, McGonigle DJ, Friston KJ, Frackowiak RS, Goadsby PJ. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med. 1999;5:836-838.
31. Wink DA, Mitchell JB. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med. 1998;25:434-456.
32. Mikhail N, Raska K, Raskova J, Degiannis D. Effect of verapamil on the IL-2 binding to its active receptor and on the release of IL-2 receptor by activated PBMC. Immunopharamacology. 1993;25:29-36.